Author:
Valenzuela-Faccini Natalia,Poveda-Henao Claudia,Flórez-Navas Catalina,Pérez-Garzón Michel,Boada-Becerra Natalia,Mercado-Diaz Mario,Salcedo Patricia,Robayo-Amortegui Henry
Abstract
Abstract
Background
The SARS-CoV-2 pandemic resulted in shortages of supplies, which limited the use of extracorporeal membrane oxygenation (ECMO) support. As a contingency strategy, polypropylene (PP) oxygenation membranes were used. This study describes the clinical outcomes in patients on ECMO with PP compared to poly-methylpentene (PMP) oxygenation membranes.
Methods
Retrospective cohort of patients in ECMO support admitted between 2020 and 2021.
Results
A total of 152 patients with ECMO support were included, 71.05% were men with an average age of 42 (SD 9.91) years. Veno-venous configuration was performed in 75.6% of cases. The PP oxygenation membranes required more changes 22 (63.1%), than the PMP Sorin® 24 (32,8%) and Euroset® 15 (31,9%) (p.0.022). The main indication for membrane change was low oxygen transfer for PP at 56.2%, Sorin® at 50%, and Euroset® at 14.8%. Renal replacement therapy was the most frequent complication with PP membrane in 22 patients (68.7%) Sorin® 25 patients (34.2%), and Euroset® 15 patients (31.9%) (p 0.001) without statistically significant differences in mortality.
Conclusion
PP oxygenation membranes was a useful and feasible strategy. It allowed a greater disponibility of ECMO support for critically ill in a situation of great adversity during the SARS-CoV-2 pandemic.
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Reference36 articles.
1. Ranney ML, Griffeth V, Jha AK. Critical Supply Shortages The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. N Engl J Med. 2020;382(18):e41. https://doi.org/10.1056/NEJMp2006141.
2. Ling RR, Ramanathan K, Sim JJL, Wong SN, Chen Y, Amin F, et al. Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis. Crit Care. 2022;26(1):1–13. https://doi.org/10.1186/s13054-022-04011-2.
3. Shekar K, Badulak J, Peek G, Boeken U, Dalton HJ, Arora L, Extracorporeal Life Support Organization Coronavirus Disease, et al. Interim guidelines: a consensus document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers. ASAIO J. 2019;2020:707–21.
4. Pourasghari H, Tavolinejad H, Soleimanpour S, Abdi Z, Arabloo J, Bragazzi NL, et al. Hospitalization, major complications and mortality in acute myocardial infarction patients during the COVID-19 era: a systematic review and meta-analysis. IJC Hear Vasc. 2022;41(March):101058. https://doi.org/10.1016/j.ijcha.2022.101058.
5. Tsangaris A, Alexy T, Kalra R, Kosmopoulos M, Elliott A, Bartos JA, Yannopoulos D. Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock. Front Cardiovasc Med. 2021;8:686558. https://doi.org/10.3389/fcvm.2021.686558.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献